Immatics Management
Management criteria checks 3/4
Immatics' CEO is Harpreet Singh, appointed in Jul 2019, has a tenure of 5.42 years. total yearly compensation is €6.38M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 1.07% of the company’s shares, worth $8.75M. The average tenure of the management team and the board of directors is 4.4 years and 3.6 years respectively.
Key information
Harpreet Singh
Chief executive officer
€6.4m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 5.4yrs |
| CEO ownership | 1.1% |
| Management average tenure | 4.4yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Immatics N.V.'s (NASDAQ:IMTX) Price Is Out Of Tune With Revenues
Sep 21
Immatics (NASDAQ:IMTX) Is In A Good Position To Deliver On Growth Plans
Jul 12Pinning Down Immatics N.V.'s (NASDAQ:IMTX) P/S Is Difficult Right Now
May 03We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
Sep 26We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
Jun 12Immatics launches $110M stock offering
Oct 10Cancer immunotherapy biotech Immatics up 18% on 4x normal volume
Jul 19Here's Why We're Watching Immatics' (NASDAQ:IMTX) Cash Burn Situation
Jan 29Analysts' Revenue Estimates For Immatics N.V. (NASDAQ:IMTX) Are Surging Higher
Dec 16Immatics N.V. (NASDAQ:IMTX) Analysts Are Pretty Bullish On The Stock After Recent Results
Apr 01What Is The Ownership Structure Like For Immatics N.V. (NASDAQ:IMTX)?
Jan 18Immatics reports Q3 results
Dec 02Immatics (IMTX) Investor Presentation - Slideshow
Nov 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -€56m |
| Jun 30 2024 | n/a | n/a | -€74m |
| Mar 31 2024 | n/a | n/a | -€80m |
| Dec 31 2023 | €6m | €488k | -€97m |
| Sep 30 2023 | n/a | n/a | -€84m |
| Jun 30 2023 | n/a | n/a | -€79m |
| Mar 31 2023 | n/a | n/a | -€68m |
| Dec 31 2022 | €7m | €522k | €38m |
Compensation vs Market: Harpreet's total compensation ($USD6.64M) is above average for companies of similar size in the US market ($USD3.24M).
Compensation vs Earnings: Harpreet's compensation has been consistent with company performance over the past year.
CEO
Harpreet Singh (49 yo)
5.4yrs
Tenure
€6,378,000
Compensation
Dr. Harpreet Singh, Ph D., has been Non-Executive Director of Immatics N.V. since July 1, 2021 and served as its Supervisory Director since 2021 until July 1, 2021. Dr. Singh serves as Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 5.4yrs | €6.38m | 1.07% $ 8.7m | |
| Co-Founder & Chief Innovation Officer | 24.9yrs | no data | 0.27% $ 2.2m | |
| Chief Financial Officer | 4.2yrs | no data | 0.14% $ 1.2m | |
| Chief Operations Officer | 1.8yrs | no data | 0.23% $ 1.9m | |
| General Counsel & Secretary | 4.4yrs | no data | 0.090% $ 732.1k | |
| Chief Development Officer | 5.2yrs | no data | 0.39% $ 3.2m | |
| Chief Medical Officer | 4.5yrs | no data | 0.19% $ 1.6m | |
| Head of Strategy | no data | no data | 0.16% $ 1.3m | |
| Co-Founder & Member of the Scientific Advisory Board | 24.9yrs | no data | no data | |
| Vice President of SEC Reporting & Accounting | less than a year | no data | no data | |
| Vice President of Marketing | less than a year | no data | no data | |
| VP of Human Resources & US Site Head | 2.4yrs | no data | no data |
4.4yrs
Average Tenure
49yo
Average Age
Experienced Management: IMTX's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 3.4yrs | €6.38m | 1.07% $ 8.7m | |
| Co-Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 3.4yrs | €263.00k | 0.046% $ 378.9k | |
| Non-Executive Chairman | 3.4yrs | €283.00k | 0.31% $ 2.6m | |
| Independent Vice Chair of the Board of Directors | 3.4yrs | €246.00k | 0.046% $ 378.9k | |
| Member of Scientific Advisory Board | 4.5yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 3.8yrs | no data | no data | |
| Independent Non-Executive Director | 3.4yrs | €259.00k | 0.046% $ 378.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.9yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.4yrs | no data | no data |
3.6yrs
Average Tenure
63yo
Average Age
Experienced Board: IMTX's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 00:48 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Immatics N.V. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alec Stranahan | BofA Global Research |
| Eric Schmidt | Cantor Fitzgerald & Co. |
| Yevgeniya Livshits | Chardan Capital Markets, LLC |